Reports

Industry Research Reports

Home > Reports > Service & Software > Microbiota Transplantation Overall Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Microbiota Transplantation Overall Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Microbiota Transplantation Overall Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-07-03

Pages: 140 Pages

Report ld: 4780246

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Microbiota Transplantation Overall Solution Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

13.5%

marketSize

Market Size,2031

USD 1,458

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 682 million
Market Forecast in 2031(Value)
US$ 1,458 million
CAGR
13.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Microbiota Transplantation Overall Solution was estimated to be worth US$ 601 million in 2024 and is forecast to a readjusted size of US$ 1458 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.

The overall solution of microbiota transplantation refers to an integrated clinical or research support service system built around diseases related to intestinal microecological imbalance through standardized donor screening, microbiota preparation, quality control, transplantation implementation and subsequent follow-up management. The solution covers the source of raw bacteria required for fecal microbiota transplantation (FMT), processing and storage, transplantation methods (such as enema, oral capsules, gastrointestinal endoscopic injection, etc.) and efficacy evaluation. It is widely used in the treatment of refractory enteritis, Clostridium difficile infection, metabolic diseases and neuropsychiatric diseases, etc., aiming to improve the accuracy, safety and operability of treatment.

North American market for Microbiota Transplantation Overall Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Microbiota Transplantation Overall Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Microbiota Transplantation Overall Solution was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Microbiota Transplantation Overall Solution include Ferring Pharmaceuticals, Seres Therapeutics, Finch Therapeutics, OpenBiome, Vedanta Biosciences, MaaT Pharma, BiomX, Entera Health, Metabiomics, J-Pharma, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Microbiota Transplantation Overall Solution, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microbiota Transplantation Overall Solution by region & country, by Type, and by Application.

The Microbiota Transplantation Overall Solution market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbiota Transplantation Overall Solution.

MARKET SEGMENTATION

By Company

  • Ferring Pharmaceuticals
  • Seres Therapeutics
  • Finch Therapeutics
  • OpenBiome
  • Vedanta Biosciences
  • MaaT Pharma
  • BiomX
  • Entera Health
  • Metabiomics
  • J-Pharma
  • KoBioLabs
  • Hangzhou Shengshi Technology
  • Ruiyi Biotechnology
  • Jiangsu Junkey Life Technology Development
  • Hangzhou Yuanxiang Medical Technology
  • MAUSOAR
  • Shanghai Chengge Biotechnology
  • Guangzhou Zhiyi Biotechnology
  • Shenzhen Unknown Jun Biotechnology
  • Sichuan Anaerobic Biotechnology

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Fresh Donor Flora Transplantation Protocol
  • Standard Frozen Flora Transplantation Protocol
  • Synthetic Flora Preparation Transplantation Protocol

Segment by Application

  • Medical and Health Industry
  • Scientific Research and Education Industry
  • Others

Segment by Category

  • Conventional Manual Preparation Scheme
  • Automated Closed System Preparation Scheme
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Microbiota Transplantation Overall Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Revenue of Microbiota Transplantation Overall Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Revenue of Microbiota Transplantation Overall Solution in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Microbiota Transplantation Overall Solution Product Introduction

1.2 Global Microbiota Transplantation Overall Solution Market Size Forecast (2020-2031)

1.3 Microbiota Transplantation Overall Solution Market Trends & Drivers

1.3.1 Microbiota Transplantation Overall Solution Industry Trends

1.3.2 Microbiota Transplantation Overall Solution Market Drivers & Opportunity

1.3.3 Microbiota Transplantation Overall Solution Market Challenges

1.3.4 Microbiota Transplantation Overall Solution Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Microbiota Transplantation Overall Solution Players Revenue Ranking (2024)

2.2 Global Microbiota Transplantation Overall Solution Revenue by Company (2020-2025)

2.3 Key Companies Microbiota Transplantation Overall Solution Manufacturing Base Distribution and Headquarters

2.4 Key Companies Microbiota Transplantation Overall Solution Product Offered

2.5 Key Companies Time to Begin Mass Production of Microbiota Transplantation Overall Solution

2.6 Microbiota Transplantation Overall Solution Market Competitive Analysis

2.6.1 Microbiota Transplantation Overall Solution Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Microbiota Transplantation Overall Solution Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiota Transplantation Overall Solution as of 2024)

2.7 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Fresh Donor Flora Transplantation Protocol

3.1.2 Standard Frozen Flora Transplantation Protocol

3.1.3 Synthetic Flora Preparation Transplantation Protocol

3.2 Global Microbiota Transplantation Overall Solution Sales Value by Type

3.2.1 Global Microbiota Transplantation Overall Solution Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Microbiota Transplantation Overall Solution Sales Value, by Type (2020-2031)

3.2.3 Global Microbiota Transplantation Overall Solution Sales Value, by Type (%) (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Medical and Health Industry

4.1.2 Scientific Research and Education Industry

4.1.3 Others

4.2 Global Microbiota Transplantation Overall Solution Sales Value by Application

4.2.1 Global Microbiota Transplantation Overall Solution Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Microbiota Transplantation Overall Solution Sales Value, by Application (2020-2031)

4.2.3 Global Microbiota Transplantation Overall Solution Sales Value, by Application (%) (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Microbiota Transplantation Overall Solution Sales Value by Region

5.1.1 Global Microbiota Transplantation Overall Solution Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Microbiota Transplantation Overall Solution Sales Value by Region (2020-2025)

5.1.3 Global Microbiota Transplantation Overall Solution Sales Value by Region (2026-2031)

5.1.4 Global Microbiota Transplantation Overall Solution Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Microbiota Transplantation Overall Solution Sales Value, 2020-2031

5.2.2 North America Microbiota Transplantation Overall Solution Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Microbiota Transplantation Overall Solution Sales Value, 2020-2031

5.3.2 Europe Microbiota Transplantation Overall Solution Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Microbiota Transplantation Overall Solution Sales Value, 2020-2031

5.4.2 Asia Pacific Microbiota Transplantation Overall Solution Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Microbiota Transplantation Overall Solution Sales Value, 2020-2031

5.5.2 South America Microbiota Transplantation Overall Solution Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Microbiota Transplantation Overall Solution Sales Value, 2020-2031

5.6.2 Middle East & Africa Microbiota Transplantation Overall Solution Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Microbiota Transplantation Overall Solution Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Microbiota Transplantation Overall Solution Sales Value, 2020-2031

6.3 United States

6.3.1 United States Microbiota Transplantation Overall Solution Sales Value, 2020-2031

6.3.2 United States Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Microbiota Transplantation Overall Solution Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Microbiota Transplantation Overall Solution Sales Value, 2020-2031

6.4.2 Europe Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Microbiota Transplantation Overall Solution Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Microbiota Transplantation Overall Solution Sales Value, 2020-2031

6.5.2 China Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031

6.5.3 China Microbiota Transplantation Overall Solution Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Microbiota Transplantation Overall Solution Sales Value, 2020-2031

6.6.2 Japan Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Microbiota Transplantation Overall Solution Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Microbiota Transplantation Overall Solution Sales Value, 2020-2031

6.7.2 South Korea Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Microbiota Transplantation Overall Solution Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Microbiota Transplantation Overall Solution Sales Value, 2020-2031

6.8.2 Southeast Asia Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Microbiota Transplantation Overall Solution Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Microbiota Transplantation Overall Solution Sales Value, 2020-2031

6.9.2 India Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031

6.9.3 India Microbiota Transplantation Overall Solution Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 Ferring Pharmaceuticals

7.1.1 Ferring Pharmaceuticals Profile

7.1.2 Ferring Pharmaceuticals Main Business

7.1.3 Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Products, Services and Solutions

7.1.4 Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.1.5 Ferring Pharmaceuticals Recent Developments

7.2 Seres Therapeutics

7.2.1 Seres Therapeutics Profile

7.2.2 Seres Therapeutics Main Business

7.2.3 Seres Therapeutics Microbiota Transplantation Overall Solution Products, Services and Solutions

7.2.4 Seres Therapeutics Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.2.5 Seres Therapeutics Recent Developments

7.3 Finch Therapeutics

7.3.1 Finch Therapeutics Profile

7.3.2 Finch Therapeutics Main Business

7.3.3 Finch Therapeutics Microbiota Transplantation Overall Solution Products, Services and Solutions

7.3.4 Finch Therapeutics Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.3.5 Finch Therapeutics Recent Developments

7.4 OpenBiome

7.4.1 OpenBiome Profile

7.4.2 OpenBiome Main Business

7.4.3 OpenBiome Microbiota Transplantation Overall Solution Products, Services and Solutions

7.4.4 OpenBiome Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.4.5 OpenBiome Recent Developments

7.5 Vedanta Biosciences

7.5.1 Vedanta Biosciences Profile

7.5.2 Vedanta Biosciences Main Business

7.5.3 Vedanta Biosciences Microbiota Transplantation Overall Solution Products, Services and Solutions

7.5.4 Vedanta Biosciences Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.5.5 Vedanta Biosciences Recent Developments

7.6 MaaT Pharma

7.6.1 MaaT Pharma Profile

7.6.2 MaaT Pharma Main Business

7.6.3 MaaT Pharma Microbiota Transplantation Overall Solution Products, Services and Solutions

7.6.4 MaaT Pharma Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.6.5 MaaT Pharma Recent Developments

7.7 BiomX

7.7.1 BiomX Profile

7.7.2 BiomX Main Business

7.7.3 BiomX Microbiota Transplantation Overall Solution Products, Services and Solutions

7.7.4 BiomX Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.7.5 BiomX Recent Developments

7.8 Entera Health

7.8.1 Entera Health Profile

7.8.2 Entera Health Main Business

7.8.3 Entera Health Microbiota Transplantation Overall Solution Products, Services and Solutions

7.8.4 Entera Health Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.8.5 Entera Health Recent Developments

7.9 Metabiomics

7.9.1 Metabiomics Profile

7.9.2 Metabiomics Main Business

7.9.3 Metabiomics Microbiota Transplantation Overall Solution Products, Services and Solutions

7.9.4 Metabiomics Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.9.5 Metabiomics Recent Developments

7.10 J-Pharma

7.10.1 J-Pharma Profile

7.10.2 J-Pharma Main Business

7.10.3 J-Pharma Microbiota Transplantation Overall Solution Products, Services and Solutions

7.10.4 J-Pharma Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.10.5 J-Pharma Recent Developments

7.11 KoBioLabs

7.11.1 KoBioLabs Profile

7.11.2 KoBioLabs Main Business

7.11.3 KoBioLabs Microbiota Transplantation Overall Solution Products, Services and Solutions

7.11.4 KoBioLabs Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.11.5 KoBioLabs Recent Developments

7.12 Hangzhou Shengshi Technology

7.12.1 Hangzhou Shengshi Technology Profile

7.12.2 Hangzhou Shengshi Technology Main Business

7.12.3 Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Products, Services and Solutions

7.12.4 Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.12.5 Hangzhou Shengshi Technology Recent Developments

7.13 Ruiyi Biotechnology

7.13.1 Ruiyi Biotechnology Profile

7.13.2 Ruiyi Biotechnology Main Business

7.13.3 Ruiyi Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions

7.13.4 Ruiyi Biotechnology Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.13.5 Ruiyi Biotechnology Recent Developments

7.14 Jiangsu Junkey Life Technology Development

7.14.1 Jiangsu Junkey Life Technology Development Profile

7.14.2 Jiangsu Junkey Life Technology Development Main Business

7.14.3 Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Products, Services and Solutions

7.14.4 Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.14.5 Jiangsu Junkey Life Technology Development Recent Developments

7.15 Hangzhou Yuanxiang Medical Technology

7.15.1 Hangzhou Yuanxiang Medical Technology Profile

7.15.2 Hangzhou Yuanxiang Medical Technology Main Business

7.15.3 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Products, Services and Solutions

7.15.4 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.15.5 Hangzhou Yuanxiang Medical Technology Recent Developments

7.16 MAUSOAR

7.16.1 MAUSOAR Profile

7.16.2 MAUSOAR Main Business

7.16.3 MAUSOAR Microbiota Transplantation Overall Solution Products, Services and Solutions

7.16.4 MAUSOAR Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.16.5 MAUSOAR Recent Developments

7.17 Shanghai Chengge Biotechnology

7.17.1 Shanghai Chengge Biotechnology Profile

7.17.2 Shanghai Chengge Biotechnology Main Business

7.17.3 Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions

7.17.4 Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.17.5 Shanghai Chengge Biotechnology Recent Developments

7.18 Guangzhou Zhiyi Biotechnology

7.18.1 Guangzhou Zhiyi Biotechnology Profile

7.18.2 Guangzhou Zhiyi Biotechnology Main Business

7.18.3 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions

7.18.4 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.18.5 Guangzhou Zhiyi Biotechnology Recent Developments

7.19 Shenzhen Unknown Jun Biotechnology

7.19.1 Shenzhen Unknown Jun Biotechnology Profile

7.19.2 Shenzhen Unknown Jun Biotechnology Main Business

7.19.3 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions

7.19.4 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.19.5 Shenzhen Unknown Jun Biotechnology Recent Developments

7.20 Sichuan Anaerobic Biotechnology

7.20.1 Sichuan Anaerobic Biotechnology Profile

7.20.2 Sichuan Anaerobic Biotechnology Main Business

7.20.3 Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions

7.20.4 Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Revenue (US$ Million) & (2020-2025)

7.20.5 Sichuan Anaerobic Biotechnology Recent Developments

muLu

8 Industry Chain Analysis

8.1 Microbiota Transplantation Overall Solution Industrial Chain

8.2 Microbiota Transplantation Overall Solution Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Microbiota Transplantation Overall Solution Sales Model

8.5.2 Sales Channel

8.5.3 Microbiota Transplantation Overall Solution Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Microbiota Transplantation Overall Solution Market Trends
Table 2. Microbiota Transplantation Overall Solution Market Drivers & Opportunity
Table 3. Microbiota Transplantation Overall Solution Market Challenges
Table 4. Microbiota Transplantation Overall Solution Market Restraints
Table 5. Global Microbiota Transplantation Overall Solution Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Microbiota Transplantation Overall Solution Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Microbiota Transplantation Overall Solution Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Microbiota Transplantation Overall Solution Product Type
Table 9. Key Companies Time to Begin Mass Production of Microbiota Transplantation Overall Solution
Table 10. Global Microbiota Transplantation Overall Solution Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiota Transplantation Overall Solution as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Microbiota Transplantation Overall Solution Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Microbiota Transplantation Overall Solution Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Microbiota Transplantation Overall Solution Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Microbiota Transplantation Overall Solution Sales Market Share in Value by Type (2020-2025)
Table 17. Global Microbiota Transplantation Overall Solution Sales Market Share in Value by Type (2026-2031)
Table 18. Global Microbiota Transplantation Overall Solution Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Microbiota Transplantation Overall Solution Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Microbiota Transplantation Overall Solution Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Microbiota Transplantation Overall Solution Sales Market Share in Value by Application (2020-2025)
Table 22. Global Microbiota Transplantation Overall Solution Sales Market Share in Value by Application (2026-2031)
Table 23. Global Microbiota Transplantation Overall Solution Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Microbiota Transplantation Overall Solution Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Microbiota Transplantation Overall Solution Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Microbiota Transplantation Overall Solution Sales Value by Region (2020-2025) & (%)
Table 27. Global Microbiota Transplantation Overall Solution Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Microbiota Transplantation Overall Solution Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Microbiota Transplantation Overall Solution Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Microbiota Transplantation Overall Solution Sales Value, (2026-2031) & (US$ Million)
Table 31. Ferring Pharmaceuticals Basic Information List
Table 32. Ferring Pharmaceuticals Description and Business Overview
Table 33. Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 34. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Ferring Pharmaceuticals (2020-2025)
Table 35. Ferring Pharmaceuticals Recent Developments
Table 36. Seres Therapeutics Basic Information List
Table 37. Seres Therapeutics Description and Business Overview
Table 38. Seres Therapeutics Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 39. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Seres Therapeutics (2020-2025)
Table 40. Seres Therapeutics Recent Developments
Table 41. Finch Therapeutics Basic Information List
Table 42. Finch Therapeutics Description and Business Overview
Table 43. Finch Therapeutics Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 44. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Finch Therapeutics (2020-2025)
Table 45. Finch Therapeutics Recent Developments
Table 46. OpenBiome Basic Information List
Table 47. OpenBiome Description and Business Overview
Table 48. OpenBiome Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 49. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of OpenBiome (2020-2025)
Table 50. OpenBiome Recent Developments
Table 51. Vedanta Biosciences Basic Information List
Table 52. Vedanta Biosciences Description and Business Overview
Table 53. Vedanta Biosciences Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 54. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Vedanta Biosciences (2020-2025)
Table 55. Vedanta Biosciences Recent Developments
Table 56. MaaT Pharma Basic Information List
Table 57. MaaT Pharma Description and Business Overview
Table 58. MaaT Pharma Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 59. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of MaaT Pharma (2020-2025)
Table 60. MaaT Pharma Recent Developments
Table 61. BiomX Basic Information List
Table 62. BiomX Description and Business Overview
Table 63. BiomX Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 64. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of BiomX (2020-2025)
Table 65. BiomX Recent Developments
Table 66. Entera Health Basic Information List
Table 67. Entera Health Description and Business Overview
Table 68. Entera Health Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 69. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Entera Health (2020-2025)
Table 70. Entera Health Recent Developments
Table 71. Metabiomics Basic Information List
Table 72. Metabiomics Description and Business Overview
Table 73. Metabiomics Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 74. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Metabiomics (2020-2025)
Table 75. Metabiomics Recent Developments
Table 76. J-Pharma Basic Information List
Table 77. J-Pharma Description and Business Overview
Table 78. J-Pharma Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 79. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of J-Pharma (2020-2025)
Table 80. J-Pharma Recent Developments
Table 81. KoBioLabs Basic Information List
Table 82. KoBioLabs Description and Business Overview
Table 83. KoBioLabs Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 84. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of KoBioLabs (2020-2025)
Table 85. KoBioLabs Recent Developments
Table 86. Hangzhou Shengshi Technology Basic Information List
Table 87. Hangzhou Shengshi Technology Description and Business Overview
Table 88. Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 89. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Hangzhou Shengshi Technology (2020-2025)
Table 90. Hangzhou Shengshi Technology Recent Developments
Table 91. Ruiyi Biotechnology Basic Information List
Table 92. Ruiyi Biotechnology Description and Business Overview
Table 93. Ruiyi Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 94. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Ruiyi Biotechnology (2020-2025)
Table 95. Ruiyi Biotechnology Recent Developments
Table 96. Jiangsu Junkey Life Technology Development Basic Information List
Table 97. Jiangsu Junkey Life Technology Development Description and Business Overview
Table 98. Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 99. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Jiangsu Junkey Life Technology Development (2020-2025)
Table 100. Jiangsu Junkey Life Technology Development Recent Developments
Table 101. Hangzhou Yuanxiang Medical Technology Basic Information List
Table 102. Hangzhou Yuanxiang Medical Technology Description and Business Overview
Table 103. Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 104. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Hangzhou Yuanxiang Medical Technology (2020-2025)
Table 105. Hangzhou Yuanxiang Medical Technology Recent Developments
Table 106. MAUSOAR Basic Information List
Table 107. MAUSOAR Description and Business Overview
Table 108. MAUSOAR Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 109. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of MAUSOAR (2020-2025)
Table 110. MAUSOAR Recent Developments
Table 111. Shanghai Chengge Biotechnology Basic Information List
Table 112. Shanghai Chengge Biotechnology Description and Business Overview
Table 113. Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 114. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Shanghai Chengge Biotechnology (2020-2025)
Table 115. Shanghai Chengge Biotechnology Recent Developments
Table 116. Guangzhou Zhiyi Biotechnology Basic Information List
Table 117. Guangzhou Zhiyi Biotechnology Description and Business Overview
Table 118. Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 119. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Guangzhou Zhiyi Biotechnology (2020-2025)
Table 120. Guangzhou Zhiyi Biotechnology Recent Developments
Table 121. Shenzhen Unknown Jun Biotechnology Basic Information List
Table 122. Shenzhen Unknown Jun Biotechnology Description and Business Overview
Table 123. Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 124. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Shenzhen Unknown Jun Biotechnology (2020-2025)
Table 125. Shenzhen Unknown Jun Biotechnology Recent Developments
Table 126. Sichuan Anaerobic Biotechnology Basic Information List
Table 127. Sichuan Anaerobic Biotechnology Description and Business Overview
Table 128. Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Products, Services and Solutions
Table 129. Revenue (US$ Million) in Microbiota Transplantation Overall Solution Business of Sichuan Anaerobic Biotechnology (2020-2025)
Table 130. Sichuan Anaerobic Biotechnology Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. Microbiota Transplantation Overall Solution Downstream Customers
Table 134. Microbiota Transplantation Overall Solution Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Microbiota Transplantation Overall Solution Product Picture
Figure 2. Global Microbiota Transplantation Overall Solution Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Microbiota Transplantation Overall Solution Sales Value (2020-2031) & (US$ Million)
Figure 4. Microbiota Transplantation Overall Solution Report Years Considered
Figure 5. Global Microbiota Transplantation Overall Solution Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Microbiota Transplantation Overall Solution Revenue in 2024
Figure 7. Microbiota Transplantation Overall Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Fresh Donor Flora Transplantation Protocol Picture
Figure 9. Standard Frozen Flora Transplantation Protocol Picture
Figure 10. Synthetic Flora Preparation Transplantation Protocol Picture
Figure 11. Global Microbiota Transplantation Overall Solution Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Microbiota Transplantation Overall Solution Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Medical and Health Industry
Figure 14. Product Picture of Scientific Research and Education Industry
Figure 15. Product Picture of Others
Figure 16. Global Microbiota Transplantation Overall Solution Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global Microbiota Transplantation Overall Solution Sales Value Market Share by Application, 2024 & 2031
Figure 18. North America Microbiota Transplantation Overall Solution Sales Value (2020-2031) & (US$ Million)
Figure 19. North America Microbiota Transplantation Overall Solution Sales Value by Country (%), 2024 VS 2031
Figure 20. Europe Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 21. Europe Microbiota Transplantation Overall Solution Sales Value by Country (%), 2024 VS 2031
Figure 22. Asia Pacific Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 23. Asia Pacific Microbiota Transplantation Overall Solution Sales Value by Region (%), 2024 VS 2031
Figure 24. South America Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 25. South America Microbiota Transplantation Overall Solution Sales Value by Country (%), 2024 VS 2031
Figure 26. Middle East & Africa Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 27. Middle East & Africa Microbiota Transplantation Overall Solution Sales Value by Country (%), 2024 VS 2031
Figure 28. Key Countries/Regions Microbiota Transplantation Overall Solution Sales Value (%), (2020-2031)
Figure 29. United States Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 30. United States Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031
Figure 31. United States Microbiota Transplantation Overall Solution Sales Value by Application (%), 2024 VS 2031
Figure 32. Europe Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031
Figure 34. Europe Microbiota Transplantation Overall Solution Sales Value by Application (%), 2024 VS 2031
Figure 35. China Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 36. China Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031
Figure 37. China Microbiota Transplantation Overall Solution Sales Value by Application (%), 2024 VS 2031
Figure 38. Japan Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 39. Japan Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031
Figure 40. Japan Microbiota Transplantation Overall Solution Sales Value by Application (%), 2024 VS 2031
Figure 41. South Korea Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 42. South Korea Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031
Figure 43. South Korea Microbiota Transplantation Overall Solution Sales Value by Application (%), 2024 VS 2031
Figure 44. Southeast Asia Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031
Figure 46. Southeast Asia Microbiota Transplantation Overall Solution Sales Value by Application (%), 2024 VS 2031
Figure 47. India Microbiota Transplantation Overall Solution Sales Value, (2020-2031) & (US$ Million)
Figure 48. India Microbiota Transplantation Overall Solution Sales Value by Type (%), 2024 VS 2031
Figure 49. India Microbiota Transplantation Overall Solution Sales Value by Application (%), 2024 VS 2031
Figure 50. Microbiota Transplantation Overall Solution Industrial Chain
Figure 51. Microbiota Transplantation Overall Solution Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Microbiota Transplantation Overall Solution in 2031?zhanKai
The global market size of Microbiota Transplantation Overall Solution in 2031 was 1458 Million USD.
What was the global market size of Microbiota Transplantation Overall Solution in 2025?shouQi
Which companies rank high in the global Microbiota Transplantation Overall Solution market?shouQi
What is the annual compound growth rate of the global Microbiota Transplantation Overall Solution market size from 2025 to 2031?shouQi
Which region is expected to have the highest market share?shouQi
den_biaoTiZhungShi

Related Reports

Microbiota Transplantation Overall Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-07-03

Pages: 140 Pages

Report ld: 4780246

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Offline

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Online

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Online

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Online

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now